Hormones and Cancer

Show Articles
Journal Properties
  • Continued as
    Discover Oncology
  • Language
    English
  • Number of Articles
    368
  • Abbreviation
    HORM CANC
  • ISSN
    1868-8497
  • e-ISSN
    1868-8500
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Description
Hormones and Cancer focuses on providing translational research in hormone-related cancers. This vital resource addresses critical topics concerning hormonal mechanisms and cancer development. This journal offers insight for researchers in oncology. The journal publishes articles on diverse areas, including breast, prostate, ovarian, and thyroid cancers, emphasizing the interplay between hormones and cancer progression. Coverage extends to endocrine disruptors, hormone therapy, and molecular signaling pathways. It also includes studies on cancer prevention, diagnostics, and innovative treatments. Indexed in major databases such as Scopus, Web of Science, and PubMed, it ensures broad visibility for published research. The target audience includes oncologists, endocrinologists, cancer researchers, and related healthcare professionals. Hormones and Cancer is committed to accelerating the translation of research findings into improved clinical outcomes. Researchers are encouraged to submit their innovative work, contributing to the advancement of knowledge and treatment strategies in hormone-related cancers. Open-access options are available to enhance the dissemination and impact of research findings.